← Back to Clinical Trials
Recruiting NCT00801333
NCT00801333 Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT00801333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hadassah Medical Organization |
| Condition | Amyotrophic Lateral Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2008-11 |
| Primary Completion | 2030-12 |
Trial Parameters
Condition Amyotrophic Lateral Sclerosis
Sponsor Hadassah Medical Organization
Study Type OBSERVATIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2008-11
Completion 2030-12
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from various types of cell cultures or lines from existing collections. The IPS cells will be developed for modeling diseases, for developing the technology that may eventually allow the use of IPS cells for transplantation therapy, and for basic research.
Eligibility Criteria
Inclusion Criteria: * Volunteers * Male and Female Exclusion Criteria: * Below the official age of consent
Related Trials
NCT05352958
Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyo
View Trial →
NCT06396260
Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect
View Trial →
NCT00801333
Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells
View Trial →
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology